Eli Lilly Reports the P-II (SYNERGY-NASH) Study Data of Tirzepatide for Treating Metabolic Dysfunction-Associated Steatohepatitis (MASH)
Read More: Eli Lilly
Moderna Reports the P-III Study Data of mRNA-1083 Vaccine Against Influenza and COVID-19
Read More: Moderna
Junshi Biosciences Reports the P-III Trial Data of Toripalimab Plus Bevacizumab to Treat Advanced Hepatocellular Carcinoma (HCC)
Read More: Junshi Biosciences
Palatin Technologies Reports the Commencement of P-II Trial Evaluating Bremelanotide to Treat Obesity
Read More: Palatin Technologies
Pfizer Reports the P-III Trial Data of Fordadistrogene Movaparvovec for Duchenne Muscular Dystrophy
Read More: Pfizer
BeiGene to Highlight Data from P-III (SEQUOIA) Study of Brukinsa in Combination with Venetoclax for CLL/SLL at EHA2024
Read More: BeiGene
Roche’s Alecensa (Alectinib) Receives the EC’s Approval as an Adjuvant Treatment for Early-Stage Lung Cancer
Read More: Roche
GSK’s Arexvy Gains the US FDA’s Approval for Expanded Age Indication to Prevent RSV Lower Respiratory Tract Disease
Read More: GSK
AstraZeneca Reports the US FDA’s sNDA Acceptance of Tagrisso to Treat Lung Cancer
Read More: AstraZeneca
Zymeworks Reports the NMPA’s BLA Acceptance of Zanidatamab to Treat Biliary Tract Cancer
Read More: Zymeworks
Ipsen’s Iqirvo (Elafibranor) Gains the US FDA’s Accelerated Approval for Treating Primary Biliary Cholangitis
Read More: Ipsen
The US FDA Grants Emergency Use Authorization to Roche’s Four-In-One Nucleic Acid Test
Read More: Roche
Regeneron’s Kevzara (Sarilumab) Gains the US FDA’s Approval to Treat Active Polyarticular Juvenile Idiopathic Arthritis (PJIA)
Read More: Regeneron
The Canadian Intellectual Property Office (CIPO) Issues Notice of Allowance for Patent Covering Palisade Bio’s PALI-2108 for Treating Ulcerative Colitis
Read More: Palisade Bio
60 Degrees Pharmaceuticals’ Tafenoquine Gains the US FDA’s Orphan Drug Designation to Treat Acute Babesiosis
Read More: 60 Degrees Pharmaceuticals
AstraZeneca’s Farxiga (Dapagliflozin) Bags the US FDA’s Approval to Treat Type-2 Diabetes in Pediatric Patients
Read More: AstraZeneca
LEO Pharma’s Adbry (tralokinumab-ldrm) Autoinjector Receives the US FDA’s Approval to Treat Moderate-to-Severe Atopic Dermatitis (AD)
Read More: LEO Pharma
Innovent’s IBI343 Gains the US FDA’s Fast Track Designation to Treat Pancreatic Cancer
Read More: Innovent
BMS Reports the US FDA’s Accelerated Approval of Augtyro to Treat Locally Advanced or Metastatic Solid Tumors
Read More: BMS
Flagship Pioneering and ProFound Therapeutics Team Up with Pfizer to Discover Novel Therapies to Treat Obesity
Read More: Flagship Pioneering & ProFound
Ochre Bio and GSK Team Up to Explore the Drivers of Liver Disease
Read More: Ochre Bio & GSK
AbbVie Teams Up FutureGen to Advance Next-Generation Therapy to Address Inflammatory Bowel Disease
Read More: Abbvie
DeepQure Reports the US FDA’s IDE Approval of HyperQure for Treating Resistant Hypertension
Read More: DeepQure
The US FDA Clears Abbott’s Two New Over-The-Counter Continuous Glucose Monitoring Systems
Read More: Abbott
Providence Medical’s CORUS Navigation Access System Gains the US FDA’s Clearance for Use in Posterior Spinal Fusion Procedures
Read More: Providence Medical
Venus Medtech Reports First Implantation of the VenusP-Valve in its Pivotal Trial Across the US
Read More: Venus Medtech
Mira Pharmaceuticals Reports Preclinical Data of Ketamir-2 to Treat Depression
Read More: Mira Pharmaceuticals
Alvotech and STADA Extend their Strategic Partnership Covering AVT03 (Biosimilar, Denosumab)
Read More: Alvotech & STADA
Moderna Reports the P-III Study Data of mRNA-1283 Vaccine to Prevent COVID-19
Read More: Moderna
